Diminution of phagocytosed perfluorocarbon emulsions using perfluoroalkylated polyethylene glycol surfactant.
Perfluorocarbon emulsions have been considered as potential blood substitutes for years due to their high capacity of dissolving respiratory oxygen and carbon dioxide. However, they have been reported to associate with side effects (e.g., flu-like syndrome) after being injected into animal's bloodstream. The cause of these side effects is related to the phagocytosis of perfluorocarbon emulsions by cells (e.g., macrophages). Inspired by the approach of using polyethylene glycol (PEG) to camouflage liposomes, we synthesized a perfluoroalkylated PEG (R(F)-PEG) surfactant to provide steric hindrance for decreasing phagocytosis of perfluorocarbon emulsions. The R(F)-PEG surfactant along with Pluronic F-68 and egg yolk phospholipid mediated perfluorocarbon emulsions were incubated individually with J774A.1 macrophages to examine the degree of phagocytosis. 19F NMR studies were used to quantitatively determine the amount of perfluorocarbon emulsions phagocytosed by macrophages. Results showed that the degree of phagocytosis was diminished to a large extent for perfluorocarbon microparticles emulsified by the R(F)-PEG surfactant.
Hsu
Y C
YC
Department of Chemical Engineering, University of Southern California, Los Angeles, California 90089-1211, USA.
Peng
C A
CA
D000478:Alkylation; D000818:Animals; D002460:Cell Line; D004655:Emulsions; D005466:Fluorocarbons / Q000276:immunology*; D008264:Macrophages / Q000276:immunology*; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D010587:Phagocytosis; D011092:Polyethylene Glycols / Q000737:chemistry*; D013501:Surface-Active Agents / Q000737:chemistry*
D004655:Emulsions; D005466:Fluorocarbons; D013501:Surface-Active Agents; D011092:Polyethylene Glycols